Jamie Triccas
@tricckylab
Professor of Medical Microbiology, Infection & Immunity theme leader @Sydney_ID Developing new ways to combat lung infections. Views my own.
ID: 1020425318941614080
20-07-2018 21:48:49
539 Tweet
809 Followers
331 Following
Hot off the press: great to see our article on new carborane inhibitors of Mycobacterium tuberculosis published in RSC Medicinal Chemistry. A joint collaboration with the Rutledge group Sydney Chemistry and Jamie Triccas Charles Perkins Centre Sydney Health #boron pubs.rsc.org/en/content/art…
How many excess deaths occurred in the first 2 years of the COVID-19 pandemic? Our new study in Science Advances finds: 1.18 million deaths. Nearly as many deaths occurred in Year 2 as Year 1 with large increases in counties in the rural South. Thread. science.org/doi/10.1126/sc…
Fantastic initiative Charles Perkins Centre to display indigenous artwork, feels like we are working in a gallery! University of Sydney #indigenousart
A big thank you to all the co-authors Claudio Nayan Bhattacharyya Jamie Triccas Warwick Britton and Carl Feng who made this exciting study on lymphocyte trafficking dynamics in lymph nodes during M.tb infection possible! Infection, Immunity & Inflammation Charles Perkins Centre PLOS Pathogens
SAVE THE DATE Our Asia-Pacific Vaccine Research Webinar 27 July 3-4PM Why do we need a new TB vaccine? Nigel Curtis Jamie Triccas Our first webinar to launch our professional development program for our Asia-Pacific Vaccine Research Network Murdoch Children's Research Institute (MCRI) UniMelb MDHS World Health Organization (WHO) Western Pacific
Really enjoyable collaboration exploring BCG vaccine protection against #Mycobacterium #abscessus infection. Insight from #CysticFibrosis cohorts+mechanistic insight from animal models, a 🧵1/6 👇Jamie Triccas Sydney ID Ben J Marais Sydney Children's Hospitals Network Children's Health and Environment Program (CHEP) mdpi.com/2076-393X/11/8…
Amazing publication from Jamie Triccas and Megan Steain and their colleagues on unique cytotoxic CD4+ T cell-signature in critical COVID-19 in Clinical & Translational Immunology bit.ly/3sxA6uB Sydney ID University of Sydney Eric Topol Centenary Institute UNSW Sydney Children's Hospitals Network Royal Prince Alfred Hospital School
New from our lab! Advax, one of the newest adjuvants licensed for human use in the COVID-19 vaccine SpikoGen®, now has a mode of action: it targets the DC-SIGN receptor. Great work by Dr Erica Stewart and collaborators. Sydney ID SP Griffith University's Institute for Glycomics doi.org/10.1111/imcb.1…
Here is our contribution to the world of TB vaccines and mRNA delivery, a great collaboration with Monash Institute of Pharmaceutical Sciences. Sydney ID Sydney Health #mRNA #vaccine A LNP-mRNA vaccine provides potent immunogenicity and protection against Mycobacterium tuberculosis biorxiv.org/content/10.110…